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Biomarkers are highly essential to improve diagnosis, confirm the diseases' development, 
and monitor the treatment. Biomarker discovery requires analysis of a large quantity of 
data which is aided by computational tools. One of the methods widely used in search of 
new biomarkers is immunohistochemistry of tissue samples.  
Numerous tools are available to detect different cell types in tissues in histological 
sections; still, the need for more advanced and quantitative analysis is growing. The most 
successful paradigms to meet these novel needs are using deep learning-based networks. 
Rab24, an atypical member of the Rab protein family, plays a role in the late steps of 
endosomal degradation, in mitochondrial plasticity, and in the clearance of autolysosomes 
in basal autophagy. Rab24 has been connected to neurodegeneration and cancer. It has 
been shown to be overexpressed in hepatocellular carcinoma (HCC) and to enhance 
HCC's malignant phenotype. These findings together indicate that Rab24 might be a 
potential biomarker for cancer, and its modulation might be used as a strategy for cancer 
therapy. 
This project was undertaken to investigate the expression of Rab24 in different types of 
human cancers. Rab24 was detected by immunohistochemical staining in cancer tissue 
samples embedded in paraffin. For the evaluation of expression levels, detailed image 
analysis pipelines were developed to combine an open-source software called QuPath 
with a deep learning network, StarDist, in order to setup a robust quantitative cell 
detection compatible with histological panoramic images. 
Based on our current analysis, 5 cancer types, including angiosarcoma, stomach 
gastrointestinal stromal tumor (GIST), rectal neuroendocrine carcinoma (NEC), 
liposarcoma and fibrosarcoma were selected as potential candidates for further 
investigation.  
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CMA - Chaperone-mediated autophagy 
DAB - Diaminobenzidine 
GDP - Guanosine diphosphate 
GDI - Guanine nucleotide dissociation inhibitor  
GIST - Gastrointestinal stromal tumor  
GTP - Guanosine triphosphate 
HCC - Hepatocellular carcinoma  
HRP - Horseradish peroxidase 
IHC - Immunohistochemistry 
NEC - Neuroendocrine carcinoma 
NET - Neuroendocrine tumor  
PBS - Phosphate buffer saline 
ROI - Region of interest  
TMA - Tissue microarray 
TBS - Tris-buffered saline 
TBST - Tween in Tris-buffered Saline 
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1.1 Biomarker discovery and data quantification 
In the past, cancer diagnosis used to rely solely on the morphological analysis of tissues 
and cells in histological sections of the tumor. This type of morphological diagnosis 
requires many years of experience, it is not quantitative, and it is challenging when it 
comes to the early stages of malignant diseases.  Every cancer develops due to changes 
at the molecular level. Therefore, studying the associated molecules is the key to 
determine cancer's type and stage precisely. Biomarkers are specific 
diagnostic/prognostic molecules and changes in their expression may indicate 
physiological and pathological conditions. Biomarkers are also helpful to ascertain the 
classical pathological diagnosis and to show the efficiency of the treatment. Many studies 
have been conducted to show the correlation of biomarkers with different diseases, as 
exemplified by the following publications. Flieswasser and colleagues (2019) showed 
that a biomarker called CD70 is commonly expressed in solid and hematological tumor 
entities. Another study revealed CDK6 as a potential biomarker for non-acute 
promyelocytic leukemia patients, a subtype of acute myeloid leukemia (non-APL AML) 
(Liu et al., 2021). Finally, Chen and colleagues (2017) showed that Rab24 upregulation 
facilitates the growth and metastasis of HCC cells. 
Early diagnosis is essential for cancer treatment as it increases the patient's chance of 
recovery. Thus, biomarker discovery has gained much attention in recent years, and 
cancer therapies are also highly linked to the progression of this field.  
1.1.1 Digital pathology and open-source tools in biomarker discovery  
Discovering new markers requires analysis of large quantities of samples, and this is time-
consuming or even impossible to be done manually; hence, computational methods need 
to be used. In particular this applies to analysis of histological samples. Despite the 
advances in digital pathology, the existing software may not be completely functional for 
addressing the needs of the new challenges, such as detecting cells that differ in size and 
shape simultaneously in one tissue section. These demands give rise to the need for more 
complex and advanced image analysis strategies. Open-source software can be one of the 





worldwide and be combined with machine learning methods. Besides, open-source 
products are beneficial for both programmers and users with no programming 
background, due to the active and supportive imaging community. Open resources have 
revolutionized digital pathology, and many findings in cancer biomarker discovery would 
not have been possible without the presence of this technology (Humphries et al., 2021).   
1.1.2 QuPath  
QuPath (Bankhead et al., 2017), short term for quantitative pathology, is an extensible 
bioimage analysis software with an open-source solution that was initially created for 
histological analysis, but fluorescence microscopy images can be analyzed using this 
software as well. It is capable of dealing with the massive size of whole slide images 
(WSIs) and enables the user to quantify the biomarkers without cropping or lowering the 
size of images taken by panoramic scanners. Thereby, it is more convenient for digital 
pathology compared to e.g. the widely used ImageJ-Fiji software.  
QuPath supports many image formats such as Digital Imaging and Communications in 
Medicine (DICOM), TIFF, and BIF. For reading MRXS format, often 3DHISTECH's 
Slide Converter needs to be installed. The flexible WSIs viewer in QuPath enables the 
user to navigate freely across the panoramic images. Besides, it allows annotating and 
classifying the tissue and tumor manually and automatically, alongside the staining 
intensity estimation. Positively stained cells can be detected, counted, and scored. QuPath 
further gives the possibility to assess tissue microarrays (TMAs) and exchange of data 
with ImageJ. Once an optimized workflow is created, it can be saved through the 
command history and run on a series of images. More advanced analysis is possible by 
batch-processing and scripting. Scripting unlocks a vast range of possibilities (Humphries 
et al., 2021; Bankhead et al., 2017; Welcome to QuPath! — QuPath 0.2.3 
documentation).  
Instructions regarding the analysis, installation, and useful tutorials for QuPath can be 
found in references (Welcome to QuPath! — QuPath 0.2.3 documentation; QuPath | 
Quantitative Pathology & Bioimage Analysis). 
QuPath's supportive community website is designed for users with no programming 







1.1.3 Limitations of QuPath 
A reliable instant nuclei segmentation method allows analyzing microscopy images to 
identify cell shape, cell size, and gene and protein expression individually. This helps to 
answer biological questions such as gene expression differences between cells 
(Humphries et al., 2021).  
QuPath is commonly used to detect, count, and score the cells from negative to 3+ (strong 
protein expression) in histologically stained tissues, and a list of commands in the 
software has been developed for this aim. The primary tool for cell detection and scoring 
in QuPath is the ''positive cell detection'' command.  
The efficiency of the positive cell detection command depends on many factors, such as 
the intensity of positive staining, the number of overlapping nuclei, and the location of 
positive staining (nucleus or cytoplasm). It has been shown that in the images of confluent 
cells, or when the positive staining is localized in the cytoplasm, this command might not 
work accurately. This inaccuracy could result in nucleus over-segmentation, detection of 
false fragmented nuclei, and consequently unreliable and biased analysis. This error is 




Figure1. False segmentation. On the left, the original image, and on the right, the same image after 
applying positive cell detection in QuPath are shown. Yellow arrows indicate two nuclei. Red arrows 
correspond to the same cells in the right image which QuPath has incorrectly segmented into two, to 






1.1.4 QuPath combination with StarDist  
The most successful paradigms to solve the nuclei detection issue are categorized in 
supervised deep learning. Using deep learning methods and their combination with 
current image analysis software enable the user to find all objects such as nuclei and 
delineate them in a very meticulous manner. In the deep learning method, the user 
formulizes the task as a prediction test with deep learning neural networks. The input 
would be one or more images containing the structures of interest and the output would 
be a segmentation of the structures of interest. Firstly, user annotates a subset of the final 
dataset by segmenting the objects in the image manually or semi-automatically. These 
images are called the training dataset and are used to produce a model by the neural 
network. The model is then applied to the unannotated dataset in order to make 
segmentation predictions. Training must be optimized for every specific dataset in order 
to get the best result. Deep learning-based analyses are very promising for cell 
segmentation.  
StarDist is a deep learning network for nuclei segmentation in 2D and 3D images, which 
is well adapted to nuclei's typical round shapes. It follows two steps; in the first step, 
instead of using foreground and background strategy (Bottom-up approach) for 
segmentation, StarDist predicts two parameters for each pixel. One parameter is an object 
probability that is computed from the ground truth, which is the distance of the center of 
each object to the next nearest boundary. This indicates the pixel's probability of being 
the center of the object. The second parameter is the radial distance, a certain number of 
radial directions that developers have predefined for every point. It indicates the distance 
to the closest boundary of the object. Therefore, it shows the distance of every pixel from 
the object boundary based on a predefined ray.  
The following step is polygon selection and maximum suppression. Polygon is 
constructed out of the distance maps and object probabilities for every point and asks 
which point overlaps or which polygons assigned to a specific point have the highest 
probability. It also asks which points should be suppressed because the corresponding 
polygon overlaps too much with an already existing polygon, and this is called maximum 
suppression. The method finally keeps the most probable object according to the predicted 
probabilities and suppresses all the predicted polygons that overlap above a certain 





StarDist are compared with each other (Latest QuPath topics - Image.sc Forum; Schmidt 





Figure 2. Positive cell detection command in QuPath vs. StarDist.  The images show the 
same area analyzed by positive cell detection command (Left) and StarDist (right). The deep learning 
approach is better adapted to the nuclei shapes, allowing to simultaneously detect cells different in shape 
and size. It reduces the number of falsely segmented nuclei (Yellow arrows) and detects them more 





1.2 Rab proteins 
Rab proteins are soluble small GTPases that orchestrate all the steps in intracellular 
vesicular trafficking, such as cargo selection, vesicle budding and transportation, vesicle 
docking and fusion. Once Rab proteins are produced, they are placed in the cytoplasm for 
post-translational modifications, leading to the attachment of prenyl groups (hydrophobic 
lipid moieties) to their C-terminals. The prenyl group is inserted into the target membrane, 
enabling the Rabs to be anchored to intracellular membranes' cytosolic side. The 
localization of Rab proteins on the vesicular membrane is vital for their activation. GDP-
bound cytosolic Rab (Rab-GDP) is the inactive form and, GTP- and membrane-bound is 
the active form of the members of this protein family (Figure 3) (Wang et al., 2017). The 
Rab protein is activated by the intervention of GDP-GTP exchange factors (GEFs). Active 
Rab can recruit its effectors and consequently perform a specific task. Inactivation of Rab 
occurs by the action of GTPase-activating proteins (GAPs), leading to hydrolysis of 
bound GTP to GDP and phosphate. In the deactivation process, Rab-GDP (inactive form) 
associates with GDP dissociation inhibitors (GDIs) and detaches from the membrane. 
Detachment is due to the GDIs hydrophobic interaction with the Rabs' prenyl group; thus, 
the prenyl group can no longer be inserted in the membrane. Dissociation of inactive Rab 
from GDI allows Rab to be activated again. As a result of this dissociation, Rab is able to 
insert its prenyl group in the target membrane, which occurs by the action of the GDI 
displacement factor (GDF) (Hutagalung and Novick, 2011). The Rab cycle in 







Figure 3. Inactive and active states of Rab proteins. GTP- and membrane-bound is Rab's 
active form, while GDP-bound cytosolic Rab is inactive. The protein is recruiting its effector once it is in 
the active state. Inactivation occurs when bound GTP hydrolyzes, producing GDP and phosphate. The 





Approximately 70 Rab proteins have been identified in humans, and each performs 
specific tasks based on the effectors it recruits. Several Rab proteins function in the 
autophagic process, including Rab1, 5, 7, 8B, 9A,11, 23, 24, 25, 32, and 33B. Rab8B and 
Rab7 play an essential role in the maturation of autophagosomes, while the role of Rab8A 
and Rab25 is still unclear. Rab24 is needed for the clearance of autolysosomes (Ao et al., 
2014; Ylä-Anttila and Eskelinen, 2018; Ylä-Anttila et al., 2015).  
1.2.1 Rab24 
Rab24 is an atypical member of the Rab family, identified by Olkkonen et al.(1993). 
Rab24 has lower GTPase activity than the other members of the Rab family, which is 
likely due to serine instead of glutamine at position 67 in the GTP binding region (Ding 
et al., 2003). Different stimulators that trigger autophagic activity, such as stress 
conditions, have been shown to upregulate Rab24 expression in some cell types, which is 
in line with Rab24's role in autophagy. Eskelinen group (Ylä-Anttila et al., 2015) has 
revealed that Rab24 functions in the clearance of autolysosomes under basal conditions. 
Apart from autophagy, Rab24 plays a role in the late steps of the endosomal degradative 
pathway (Amaya et al., 2016), and additionally, it controls mitochondrial plasticity in the 
liver by interacting with the mitochondrial fission protein Fis1 (Seitz et al., 2019). The 
exact molecular mechanisms of Rab24 in autophagy are still unclear. 
1.2.2 Autophagy  
Autophagy is a dynamic, highly regulated intracellular degradation mechanism, which 
takes place in eukaryotic cells. It breaks down redundant intracellular components within 
the lysosome to clean the cell of toxic proteins, defends against pathogens, and recycles 
damaged organelles. The degradation products can then be reused to produce energy, 
maintain homeostasis, and promote healthy cells' regeneration. Therefore, autophagy is a 
critical process for cellular homeostasis, and its dysregulation is connected to several 
diseases (Klionsky, 2008).  
The general term autophagy refers to 3 types of autophagy: Macroautophagy, 
microautophagy, and chaperone-mediated autophagy (CMA) that all share the same 
characteristic, which is the degradation of cytosolic components within the lysosome.  
In microautophagy, the degradation occurs after the direct engulfment and internalization 
of cytoplasmic components at the lysosomal membrane via invagination and formation 





CMA is a selective degradation process that targets soluble intracellular proteins with 
specific amino acid sequences, serving as ''zip codes'', exposed on their surface. The 
process requires chaperone proteins to recognize the zip codes, transport of the proteins 
to the lysosomal surface, and delivery of the cargo through the lysosomal membrane 
directly into the lysosomal lumen for degradation. CMA occurs during long periods of 
fasting, typically longer than 12 hours in cultured cells  (Dong et al., 2020). 
Macroautophagy is a highly regulated degradation process that begins at the endoplasmic 
reticulum. Cellular components are engulfed by a developing, cup-shaped membrane 
called the phagophore, leading to the formation of a double membrane autophagosome. 
The autophagosome transports the selected cargo to a lysosome-rich area, fuses with the 
lysosomal membrane, and releases the autophagic cargo inside the lysosome for 
degradation (Figure 4) (Feng et al., 2014). Compared to CMA, macroautophagy is 
induced by a shorter period of starvation (Mizushima et al., 2002). 
Macroautophagy is an umbrella term for various types of autophagy that all utilize 
autophagosomes. Macroautophagy can be either non-selective or selective. Different 
types of selective autophagy are named according to the cargo, i.e., mitophagy, 
reticulophagy, nucleophagy, lipophagy, aggrephagy and xenophagy which refer to the 
degradation of mitochondria, endoplasmic reticulum, nucleus, lipids or lipid droplets, 
















Figure 4. Macroautophagy. Selected cargo is engulfed by a cup-shaped structure called the 
phagophore that develops and leads to autophagosome formation. Autophagosome fuses with the lysosome, 
or vacule in yeast, and releases the autophagic bodies inside the lysosomal or vacuolar lumen. The cargo is 
degraded by the lysosomal hydrolases and enzymes. The drawing also shows microautophagy of 
peroxisomes. Permeases transport degradation product back to the cytoplasm. The image is from Reference 
(Feng et al., 2014). 
Autophagy is subdivided into two modes: Induced and basal autophagy. Induced 
autophagy is caused by stress such as starvation, hypoxia, the presence of pathogens, and 
chromosomal damage. On the other hand, basal autophagy constantly occurs at low level 
in most cell types under basal conditions when nutrients are present, to maintain 
homeostasis (Russell et al., 2014). 
The autophagic process declines with aging, which causes impairment in cellular and 
tissue homeostasis. This reduction is partially due to the diminished proteolytic ability of 
lysosomes and the upregulation of the protein Rubicon, which inhibits autophagosome 
maturation. The less autophagic activity, the more toxic proteins accumulate, and 
dysfunctional organelles also become prone to accumulation. This accumulation can 
result in diseases such as neurodegeneration and cancer. Hence, autophagy is receiving 
much attention due to its potential role in longevity and preventing diseases such as cancer 





initiation in early tumorigenesis or, paradoxically, behave in favor of the cancer cell 
survival and metastasis in later stages of cancer (Yun and Lee, 2018). Autophagy 
modulators (both inhibitors and activators) are currently being used in clinical trials 
(Marinković et al., 2018).  
 
1.2.3 Endosomal degradative pathway 
Extracellular components are internalized into cells through endocytosis. The cargo is 
transported in plasma membrane-derived vesicles to early endosomes (EE). 
Subsequently, they are either recycled back to the plasma membrane or transported to late 
endosomes (LE) for fusion with lysosomes for degradation. There are several regulators 
for the endocytic pathway, including some of the Rab protein family members. Rab 7 and 
Rab24 are localized in LE compartments. Rab7 regulates the late endocytic membrane 
trafficking and functions in the maturation of endosomes, similar to its role in autophagy. 
RILP (Rab interacting lysosomal protein) is a downstream effector that binds to Rab 7 in 
the active form. Rab24-Rab7-RILP complex allows endosome-lysosome fusion. Rab24 
is also essential for activating Rab7 and for its attachment to the membrane (Amaya et 
al., 2016).  
 
1.2.4 Mitochondrial plasticity 
Mitochondria are dynamic organelles that convert energy for the cellular processes due 
to the different nutritional conditions or energy status changes, to optimize ATP 
production in the cells. Mitochondria undergo dynamic fusion and fission. Rab24 was 
recently shown to regulate the mitochondrial fission in liver, by interacting directly with 
mitochondrial fission 1 protein (FIS1). This interaction is suggested to assist the 
recruitment of dynamin-related protein 1 (DRP1) to the mitochondrial membrane to drive 
fission. Mitochondrial fission plays a role in organelle plasticity under basal conditions. 
Fission is also required for mitochondrial degradation via mitophagy. Therefore, Rab24 
inhibition in liver leads to less mitochondrial fission, less mitophagy, and more 






1.2.5 Rab24 as a potential biomarker for cancer 
Chen et al. (2017) showed that the over-expression of Rab24 facilitates the growth and 
metastasis of HCC  cells both in vitro and in vivo. HCC is a lethal type of liver cancer, 
which occurs in patients with chronic liver diseases. The pathogenesis of HCC is not well 
understood. Recently, many reports have described a regulatory class of RNAs called 
microRNAs (miRNAs), which play a role in the pathogenesis of many cancers, including 
HCC. MicroRNA-615-5p was shown to be downregulated in HCC. This microRNA 
downregulates Rab24 expression; thus, the low level of miRNA-615-5p leads to the 
upregulation of Rab24, which was shown to lead to the promotion of cell migration, 
epithelial-mesenchymal transition, and ultimately invasiveness of HCC (Chen et al. 
2017). The overexpression of Rab24 in HCC has been confirmed by two other research 
groups (He et al., 2002; Qin et al., 2021). In addition, Human Protein Atlas (Expression 
of RAB24 in cancer - Summary - The Human Protein Atlas) shows and high expression 
of Rab24 is a poor prognostic marker in liver and renal cancer.  Cosmic cancer mutation 
database (COSMIC | Catalogue of Somatic Mutations in Cancer) shows that Rab24 is 
overexpressed in 14.5% (54 of 373) of HCC cases and in 11% (67 of 600) of renal cancers. 
 
2. Aim and hypothesis 
 
Despite all achievements in cancer biomarker discovery, for certain cancer types no 
biomarkers have been discovered yet. Biomarker insufficiency may lead to late diagnosis, 
cancer progression, and less chance of survival. Biomarkers are also used as tools to 
monitor the effectiveness of cancer treatments. Rab24 has been shown to be 
overexpressed in HCC and renal cancer, and we hypothesize it might be a potential 
biomarker for other cancer types as well.  
This research project aimed to study the expression of Rab24 protein in 21 different 
human cancers using immunohistochemical staining of tissue microarrays obtained from 
the Helsinki biobank. To analyze the intensity of Rab24 staining, I developed quantitative 
image analysis pipelines using QuPath software combined with the deep learning network 






3. Material and methods 
 
Tissue microarray (TMA) blocks containing samples from 21 different types of human 
cancer belonging to 54 patients (n=54) were obtained from the Helsinki biobank. The 
paraffin sections of these TMAs were stained for Rab24 using immunohistochemistry 
(IHC). Antibody validation for Rab24 antibodies was performed using Rab24 knockout, 
overexpressing and control cells in Western blotting. The following Neuro-2a cell lines 
were used: wild type (WT), Rab24 knockout (10G1), and GFP-tagged Rab24 
overexpressing.  
3.1 Western blotting for Rab24 antibody validation 
3.1.1 Sample preparation 
In this section, all the steps were performed on ice.  
The cells were scraped off the dish and collected in 1X PBS (140 mM NaCl, 2.7 mM 
KCl, 4.6 mM Na2HPO4 2H2O, 1.5 mM KH2PO4, pH 7.4) followed by pelleting for 3 
minutes at 400 g at 4°C. Next, the supernatant was aspirated, and the pellet was 
resuspended in lysis buffer (RIPA; 50 mM Tris-HCl pH7.4, 150 mM NaCl, 1 mM EDTA, 
1%Triton X-100 and Pierce protease inhibitor mini tablets). The suspension was then 
rotated for 40 minutes at +4°C. After the incubation, the suspension was centrifuged at 
16000 g for 15 minutes at +4°C. Subsequently, the supernatant containing the total extract 
was collected and stored on ice. The total extract's protein concentration was measured 
using the BCA protein assay (Thermo Scientific, 23228). Absorbance was measured with 
Ensight Multimode Microplate Reader (Perkin Elmer) at 562 nm. Samples were prepared 
by adding 4X loading buffer (Laemmli buffer, 0.2 M Tris-HCl, pH 6.8, 8% sodium 
dodecyl sulfate (SDS), 20% 2-mercaptoethanol, 0.004% bromophenol blue), then 
vortexed and boiled at +95°C for 5 minutes. Ultimately, the samples were stored at -20°C 
until further use.  
3.1.2 Running the samples on the gel 
12% SDS-PAGE gel was prepared to run the samples. The samples were melted and 
boiled at +95°C for 3 minutes. 10 g of total protein were loaded in each well alongside 
with 5 l of molecular weight standard PageRuler Prestained Protein Ladder Plus 





(Bio-Rad) filled with 1X running buffer initially at 50V for 20 minutes followed by 120V 
for 90 minutes. Next, the gel was incubated in 1X complete blotting buffer (Tris 0.025M, 
Glycine 0.2M, Methanol 20%, pH 7.6) on the shaker for 30 minutes. Afterwards, PVDF-
membrane (Roth) activation was done in methanol for 20 seconds and then the membrane 
was equilibrated in blotting buffer for 15 minutes. Gel was placed on PVDF and run at 
250 mA for 90 minutes at +4°C using a mini Transblot Electrophoretic transfer cell 
system (Bio-Rad) filled with blotting buffer. Later, the membrane was blocked in a 
blocking solution (5% milk powder in 1X TBST (0.05% Tween in Tris Buffered Saline)) 
for 30 minutes at RT on a shaker. 
 
3.1.3 Antibody staining of blots 
All antibodies were diluted in 5% milk powder in 1X TBST. 
The membranes were incubated in the primary antibodies (Table 1) placed in falcon tubes 
on a rotator at RT for one hour or overnight at +4°C. Membranes were washed with TBST 
3 times for 10 minutes to minimize the non-specific binding of antibodies, and 
subsequently incubated in horseradish peroxidase (HRP)-conjugated secondary 
antibodies (Table 2) for one hour at RT (on a shaker). After the incubation was over, the 
membranes were washed with TBST three times for 10 minutes. Chemiluminescence was 
detected using Clarity Western ECL Substrate (Bio-Rad, Cat. #170-5061), and images 
were acquired by Sapphire Biomolecular Imager (Azure Biosystems). For 
chemiluminescence detection, ECL kit solutions were mixed together with the ratio of 
1:1, and small drops of the mixture were applied on a cling film. Then, the membranes 
were placed on the drops upside down for 3 to 5 minutes. Finally, the membranes were 










Table 1. Primary antibodies used in Western blot. 
 
 
Table 2. Secondary antibodies used in Western blot. 
 
Secondary antibodies Produced in Source Antigen Dilution  
Anti-mouse HRP Goat 
Jackson 
Laboratory Mouse IgG 
1:20000 (WB) 
 
Anti-rabbit HRP Goat 
Jackson 
Laboratory 
Rabbit IgG 1:20000 (WB) 
 
3.1.4 Western blot image analysis  
To analyze Western blot images, each protein band's intensity was measured using 
ImageJ (Fiji) software. Initially, the grey mean value was checked through the 
"Analyze"> "Set the measurement" route in the software. Then the region of interest 
(ROI), which was the protein band at the first lane, was selected using the rectangle tool 
in Fiji through the following pathway: "Analyze"> "Gels"> "Select the first Lane 
pathway". The rectangle covered the protein band, for which we aimed to measure the 
intensity. For measuring other protein bands, we covered them by the same frame. The 
intensity was measured through running "Analyze"> "Gel"> "Plot Lanes". Once the plot 
appeared, the area under the curve was selected by wand (tracing) tools.  The "result" 
window appeared, and intensity values were exported to an excel file. The normalization 





















was done by dividing antibody intensity by the loading control intensity. The loading 
control (tubulin) was stained and measured to normalize for difference in sample loading 
and transfer. 
3.2 Immunohistochemistry 
In immunohistochemical staining all the incubations took place in RT. 
This method detects the antigen of interest in tissue sections employing immunological 
and chemical reactions. First, the sections were deparaffinized by submersion in xylene 
(2 x 10 minutes) and rehydrated by graded ethanol series from absolute to 50% ethanol 
(2 x 3 minutes) and water (2 x 5 minutes). Next, the sections were incubated in 3% 
hydrogen peroxide diluted in methanol for 20 minutes to block the endogenous 
peroxidase activity, then rinsed with water and 1X PBS (140 mM NaCl, 2.7 mM KCl, 4.6 
mM Na2HPO4 2H2O, 1.5 mM KH2PO4, pH 7.4) for 5 minutes. For antigen retrieval, the 
sections were boiled in citrate buffer (10 mM Sodium citrate, 0.05% Tween 20, pH 6.0) 
for 15 minutes in a microwave oven (600W). Soon after boiling, the sections were cooled 
down to RT and washed in Tris-buffered saline (TBS, 150 mM NaCl, 50 mM Tris-Cl, pH 
7.5). Permeabilization took place by placing the sections in TBST (TBS + 0.05% Tween 
20) + 0.1% Triton X-100.  Blocking was done for 1 hour using 5% normal goat serum for 
rabbit Rab24, diluted in TBS. Eventually, the sections were covered with the primary 
antibody (Table 3) diluted in TBS overnight at +4°C. The next day, sections were rinsed 
in PBS (3 x 5 minutes), incubated in secondary antibody (Table 4) at RT for 1 hour, and 
rinsed again with PBS (3 x 5 minutes). The sections were covered by enhancer solution 
(ABC Elite (Avidin/Biotin) Systems, Vector laboratories, #Cat No. PK-6101 diluted in 
PBS for 40 minutes, and subsequently, rinsed with PBS (3 x 5 minutes). The sections 
were covered with diaminobenzidine (DAB, Vector laboratories, #Cat No. SK-4100) 
diluted in PBS for 2.5 minutes, placed in MilliQ water, and finally counterstained with 
hematoxylin for 10 seconds. After rinsing with tap water, the sections were dehydrated 
by 70%, 95%, and 100% ethanol (2 x 3 minutes) and xylene (2 x 5 minutes). After 
dehydration, mounting was done using PERTEX mounting medium.  
Image acquisition was done by Pannoramic P1000 – 3DHISTECH Ltd slide scanner, at 






Table 3. Primary antibodies used in immunohistochemistry. 
 
Primary antibodies Produced in Source Cat No. Dilution  
Anti-Rab24 
polyclonal antibody 
Rabbit Proteintech 11445-1-AP 1:400 
 





























3.2.1 Histological quantitative image analysis 
Software installation 
To set up a robust quantitative histological image analysis method, I combined the open-
source QuPath with StarDist. To do this, TensorFlow, an open-source software math 
library for machine learning was required. It focuses mainly on training and interference 
of deep neural networks. Because TensorFlow is not included in the main QuPath 
distribution, I needed to build QuPath from the source (Building QuPath | Pete’s blog).  
Once the installation was complete, QuPath was used to follow the workflow described 
below: 
 
1. Opening the image  
 
Images were opened by importing the image using the "File"> "open" path or by dragging 
and dropping the image onto QuPath's main window. 
At the beginning of opening an image, the software asks for the image type. In this 
experiment, Hematoxylin and DAB were used as chromogens; therefore, H-DAB was 
selected as image type.  
If there are more than one image to analyze, a project can be created, and all images can 
be opened in that project. For this, the user creates a new folder, clicks on the "project" 
on the left-hand pin, selects "create project" button and then chooses the newly created 
folder. The series of images can be added to the new project by following "Add images," 
"choose file," select the images, and "Import" pathway in the "Project" pin. One of the 
benefits of creating a project is that switching between related images is more 
straightforward. Besides, by clicking on the next image in the project, the software will 
ask if the user wants to save the changes done on the previous image. By clicking "yes," 
all the changes will be saved in a new folder created for the project into a data subfolder 








2. Checking image properties  
 
By clicking on the "image" tab on the left-hand pin, some of the primary metadata, 
including the image name, path, pixel size, image type, and stain vector, can be seen 























Figure 5. Image tab in QuPath. In this tab, some of the basic metadata, such as pixel size, 









3. Setting stain vectors  
 
This step is not always necessary and does not affect the quantitative analysis 
significantly. However, stain vectors are the key to color deconvolution and are useful 
when the user wants to refine the stain estimate that QuPath uses by default. Stain vectors 
characterize which color values the blue and brown colors have for hematoxylin and 
DAB. To refine the values, a small rectangle was drawn that covered the nucleus area, 
which represented pure hematoxylin color. Then by double-clicking on "Stain" belonged 
to hematoxylin on the left-hand pin in the "image" tab and selecting "yes," slightly 
modified stain vector was seen (Figure 6). The same steps were repeated for DAB and 
















Figure 6. Image pin, setting stain vectors. Image on the left demonstrates the stain 
estimation for hematoxylin that QuPath uses by default. Image on the right shows a slightly 
changed value for stain estimation after modification. The red arrow shows the annotation, which 









4. Creating TMA grid 
 
Selecting multiple tissue samples in TMAs at once is essential to receive data per tissue 
core in an arranged manner. Detecting cells in each tissue core individually is time-
consuming. Therefore, an organized web of annotations (TMA grid) is required. To do 
this, first, a rectangle was drawn to select all tissue cores together. The script described 
in Text box 1 was then run to create annotations that cover tissue cores separately in one 
slide. The user can adjust the number of horizontal and vertical annotations depending on 
the number of tissue cores in each row and column in one slide. By adjusting size and 
position of the annotations manually, all cores were fully covered (Figure 7). All scripts 
used in the analysis are released with the author's permission and optimized for our project 




































// Enter the number of horizontal & vertical cores here 
int numHorizontal = 10 
int numVertical = 17 
// Enter the core diameter, in millimetres 
double diameterMM = 1.25 
 
// Convert diameter to pixels 
double diameterPixels = (diameterMM * 1000) / 
getCurrentImageData().getServer().getPixelCalibration().getAveragedPixelSizeMicrons() 
 
// Get the current ROI 
def roi = getSelectedROI() 
 
// Create the cores 
def cores = [] 
double xSpacing = roi.getBoundsWidth() / numHorizontal 
double ySpacing = roi.getBoundsHeight() / numVertical 
for (int i = 0; i < numVertical; i++) { 
        for (int j = 0; j < numHorizontal; j++) { 
        double x = roi.getBoundsX() + xSpacing / 2 + xSpacing * j 
        double y = roi.getBoundsY() + ySpacing / 2 + ySpacing * i 
        cores << PathObjects.createTMACoreObject(x, y, diameterPixels, false) 
    } 
} 
 
// Create & set the grid 








5. Numbering of TMA cores 
 
The tissue cores in the TMAs were numbered starting from 1, to easily distinguish the 
measurements from each other (Figure 8). The script described in Text box 2 was run to 










Figure 8. TMAs before and after numbering the cores. 
Tissue core numbers can be seen in hierarchy pin.  
 
 












6. Commenting  
 
Commenting on each tissue core was done by right-clicking the TMA grid and following 
the "TMA" > "Add TMA note" path. Comments can be seen through the Hierarchy tab. 
 
7. Manual classification  
 
In QuPath, cells can be categorized into different classes such as tumor, stroma, immune 
cells, and positive/negative cells. Classifying a group of cells helps the user to analyze 
which cell types the positivity of staining is focused in. The classification was done using 
two classification strategies. First, manual classification was done after the commenting 
step, by annotating the region of interest (such as the tumor) manually. For this, QuPath's 
list of tools, including rectangle, brush, and wand tools, were used. Then the cells were 
classified through the following pathway: right click on the annotation > "Set class" > 
choose the category.  
In this study, tissues were classified into four categories: epithelial tissue, connective 
tissue, connective tissue mixed with muscle, and muscle tissue. New classes can be 
defined by going to the left-hand pin, clicking on the Annotations button, and selecting 
"Add a class." 
Train a cell classifier command was also applied to improve the manual classification by 
training the cells automatically. This command is explained in section 9. Note that 
shortcut Ctrl+L was used to access the list of commands and search bar (Cell 












8. Positive cell detection  
 
This step aimed to detect, count, and score the cells inside each tissue core and annotation. 
The aim was to score the staining intensity of Rab24 IHC reaction. To this end, the 
positive cell detection (Detecting positive cells | Pete’s blog) command was run by 
searching in the list of commands (Ctrl+L) or by running the "Analyze" > "Cell analysis" 
> "Positive cell detection." The action brought up a dialog containing adjustable 
parameters related to cell detection. These parameters included detection image, pixel 





























Key parameters are described below: 
 
I. Choose detection image 
 
The protein of interest, Rab24, was expected to be localized in the 
cytoplasm (brown DAB). "Hematoxylin OD" does not work well for 
analysis of the parts stained brown. It gives the brown color a low value 
after the stain separation, resulting in biased detection and over 
fragmentation of some nuclei. Instead, "optical density sum" was used, 
which uses all the brightness information regardless of the stain color, 
gives a higher value for positive nuclei, and thus improved the detection. 
 
II. Requested pixel size 
 
This parameter defines the image resolution the QuPath will run the 
detection on. By clicking on the "image" button in the left-hand pin, image 
pixel size was shown. Our image pixel size was 0.1213 m, but we 
preferred not to run the detection on the actual resolution and used 0.5 m 
instead. Using this value showed a more accurate detection. 
 
III. Background radius and threshold 
 
These parameters are relatively important when it comes to improving 
detection.  
QuPath subtracts the background value from every pixel of the image 
during the detection. After that, it will use a threshold that defines the 
pixels that will pass that threshold and will be detected. For our 
measurement, the optimal value for background radius was 8. The 










IV. Median filter radius and sigma  
 
These parameters were used to fix the blurred or fragmented nuclei. For 
reducing the number of false fragmented nuclei, higher values need to be 
used. The optimal values for our analysis were 0.5 and 1.75 for median 
filter and sigma, respectively. 
 
V. Minimum area and maximum area 
 
These parameters define the smallest and largest nuclei that are allowed to 





Threshold works based on maximum background intensity. It tells QuPath 
not to apply the detection if the background is above a certain threshold. 
This is useful to avoid section folds. The optimal value for our purpose 
was 0.1. 
 
VII. Split by shape box 
 
This parameter works similar to the watershed, a transformation defined 
on binary images that separates adjacent nuclei from one another. 
 
VIII. Exclude DAB box 
 
By ticking this box, QuPath avoids detecting pixels where the DAB value 
is higher than the hematoxylin value. It is mainly used when the DAB 









IX. Cell expansion 
 
Cell expansion estimates the cell size based upon distance from the 
nucleus and other nuclei's proximity. The optimized cell expansion value 
for this project was 6 m. 
 
X. Make a measurement box 
 
Make a measurement was used in this study in order to get the 
measurements per cell. 
 
XI. Score compartment and thresholds 
  
DAB OD mean as score compartment was selected. The optimal threshold 
values for scoring the cells were 0.06, 0.14, and 0.28 for 1+ (Weekly 
positive), 2+ (Moderately positive), and 3+ (Strongly positive), 
respectively. Below 0.06 was considered negative. These values were 
selected to train data after discussion with Professor Ilmo Leivo, a 
specialist in pathology.  
Positive cell detection analysis can be applied to the tissues at once using the script in 
Text box 3. 
Text Box 3. Positive cell detection script (Groovy language) 




setColorDeconvolutionStains('{"Name" : "H-DAB modified", "Stain 1" : "Hematoxylin", "Values 1" : "0.65892 0.58493 0.47294 ", "Stain 2" : 
"DAB", "Values 2" : "0.26211 0.4832 0.83535 ", "Background" : " 252 252 253 "}'); 
runPlugin('qupath.imagej.detect.cells.PositiveCellDetection', '{"detectionImageBrightfield": "Optical density sum",  "requestedPixelSizeMicrons": 
0.5,  "backgroundRadiusMicrons": 8.0,  "medianRadiusMicrons": 0.5,  "sigmaMicrons": 1.75,  "minAreaMicrons": 5.0,  "maxAreaMicrons": 
1000.0,  "threshold": 0.1,  "maxBackground": 2.0,  "watershedPostProcess": true,  "excludeDAB": true,  "cellExpansionMicrons": 6.0,  
"includeNuclei": true,  "smoothBoundaries": true,  "makeMeasurements": true,  "thresholdCompartment": "Cytoplasm: DAB OD mean",  





Even though we optimized positive cell detection command parameters to get the most 
reliable result, many false fragmented nuclei could not be excluded. To fix this, instead 
of using positive cell detection command, the Deep learning network StarDist was run in 
QuPath. To run StarDist on the image, the modified StarDist script described in Text box 
4 was run.  
Text box 4. Script for running StarDist (Groovy language)  
import qupath.tensorflow.stardist.StarDist2D 
// Specify the model directory (you will need to change this!) 
def pathModel = "C:\\Users\\Safaze\\Desktop\\he_heavy_augment" 
 
def stardist = StarDist2D.builder(pathModel) 
        .threshold(0.1)              // Probability (detection) threshold 
//        .channels('DAPI')            // Select detection channel 
        .normalizePercentiles(1, 99) // Percentile normalization 
        .pixelSize(0.5)              // Resolution for detection 
        .cellExpansion(5.0)          // Approximate cells based upon nucleus expansion 
        .cellConstrainScale(1.5)     // Constrain cell expansion using nucleus size 
        .measureShape()              // Add shape measurements 
        .measureIntensity()          // Add cell measurements (in all compartments) 
        .includeProbability(true)    // Add probability as a measurement (enables later filtering) 
        .build() 
// Run detection for the selected objects 
def imageData = getCurrentImageData() 
def pathObjects = getSelectedObjects() 
selectTMACores() 
if (pathObjects.isEmpty()) { 
    Dialogs.showErrorMessage("StarDist", "Please select a parent object!") 










StarDist does not grade the cells based on their intensity. To score the cells, cell intensity 
classification (Figure 10) was run through the following pathway: "Classify" > "Object 
classification" > "Set cell intensity classification." The optimal values for scoring the cells 











9. Training a cell classifier  
 
Trainable Classification was done at this stage to improve the manual Classification. 
Classifier dialog was brought up in QuPath, running "Classify" > "Object classification" 
> "Older classifiers" > "Create detection classifier" (Figure 11). Next, the annotation tools 
were applied to give QuPath examples of different cell types in each class. For this, 5 to 
7 cells were annotated and classified into different classes similar to section 7.  Then 
"Auto-update" button in the classifier dialog was selected in order to classify all the cells 


































10. Measurement tables and exporting the data 
 
Ultimately, the output was seen in TMA/annotation measurement tables through the 
following path: "Measure"> "Show annotations/TMA measurements." 
The results were exported using the save button in "TMA/annotation measurements" 
tables. Annotation measurements were sorted into different classes that were defined 
previously. The script in Text box 5 was run before exporting the result in order to connect 
each annotation to the corresponding tissue core (Exporting measurements — QuPath 





Text box 5. Script for assigning an annotation to be below a TMA core based on its 




















def hierarchy = getCurrentHierarchy() 
def tmaGrid = getCurrentHierarchy().getTMAGrid() 
def unassigned = getAnnotationObjects().findAll {it.getParent().isRootObject()} 
removeObjects(unassigned, true) 
 
for (annotation in unassigned) { 
    def roi = annotation.getROI() 
    def core = PathObjectTools.getTMACoreForPixel(tmaGrid,roi.getCentroidX(), 
roi.getCentroidY()) 













4.1 Rab24 antibody validation  
Rabbit anti-Rab24 (polyclonal, Proteintech, Cat No. #11445-1-AP) was used for the IHC 
since it had been used for IHC in a published paper. Proteintech website shows a Western 
blot of mouse brain lysate, stained with this antibody, where only one band is visible at 
the expected position of 23 kDa (RAB24 Antibody 11445-1-AP | Proteintech). The 
website also shows images of IHC staining with this antibody. Western blotting of 
wildtype and Rab24 knockout Neuro-2a cells was used to validate the specificity of the 
antibody.   
 
4.1.1 Western blot for antibody validation 
WT and Rab24 knockout (Rab24-/- clone10G1), and GFP-tagged Rab24 overexpressing 
Neuro-2a cell lines were used as samples. Unexpectedly, in addition to the expected 
Rab24 band at 23 kDa in WT cells, we saw two additional bands above 50 kDa in both 
WT and Rab24 knockout cells (Figure 12A, B). The nature of these unspecific bands is 
currently unknown. Since the rabbit anti-Rab24 gave unspecific bands in Western 
blotting, we tested a mouse anti-Rab24 (monoclonal, BD transduction, Cat No. #612174), 
in addition to the rabbit anti-Rab24, in Western blot with the Neuro-2a cell lines. In this 
case, the upper part of the blot was used for staining with other antibodies, so the 
unspecific bands over 50 kDa are not visible. Nevertheless, both rabbit anti-Rab24 and 
mouse anti-Rab24 show the endogenous Rab24 band at 23 kDa in wildtype cells, and no 
band in the Rab24-/- cells (Figure 12B). The mouse anti-RAB24 used for the 
immunoblotting is not recommended for IHC by the manufacturer. Our preliminary 
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Figure12) Western blot for antibody validation. Rabbit anti-Rab24 (panels A, B) and 
mouse anti-Rab24 (panel B) were used to staining Western blots of wildtype (WT), Rab24-/- (10G1), 
and GFP-Rab24 overexpressing Neuro-2a cell extracts. The minus signs indicate medium (-) and 
low (--) expression levels of GFP-Rab24. Note that the GFP-Rab24 expressing cells do not have 
endogenous Rab24.  Yellow arrow in panel A shows the weak band for endogenous Rab24 in WT 
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4.2 TMA quantification 
After performing IHC and image acquisition on the paraffin sections of the TMAs, 
StarDist was run on QuPath to analyze the images. The output produced data regarding 
the number of detected cells in TMA cores and annotations, categorized in different 
staining intensity groups. The measurement tables also provided an index called "histo" 
score or H-score. H-score is a quantitative evaluation index that takes different staining 
intensities viewed at various magnifications into account. This is done by adding the 
intensity to the percentage of positive cells. H-score in QuPath was calculated for all the 
detected cells in each cancer core and also for each tissue type in each cancer core 
classified in different subgroups known as epithelial, connective, connective and muscle, 
and muscle tissues.   
H-score is calculated using the following formula:  
H-score = [1 × (% cells 1+) + 2 × (% cells 2+) + 3 × (% cells 3+)].  
 
The H-score method assigns a score of 0 - 300 for each tissue core and annotation. The 
discriminatory threshold can be set at a certain value based on the staining and the aim of 
the study. It should be noted that in addition to overexpression of Rab24, very low Rab24 
expression could also be potentially valuable as a biomarker. Therefore, much importance 
was placed on H-scores calculated from all cells in each cancer core, significantly higher 
or lower than our on-slide liver control (H-score 164). For this reason, cancer tissues with 
H-scores more than 180 and less than 90 were selected as potential candidates for further 
investigation. Cancer tissues with H-scores < 40 and > 210 were excluded due to the 
biologically plausible cutoffs (Mazières et al., 2013; April 10, 2015 - Calculating H-Score 
- The ASCO Post; QuPath H-Scoring - Image Analysis - Image.sc Forum). Most of the 
tissue cores belonging to the angiosarcoma, stomach GIST, and rectal NEC were ranked 
the highest, and liposarcoma and fibrosarcoma were ranked the lowest based on the H-
scores. Furthermore, there was less fluctuation in the H-scores among different patients 








4.2.1 Classification of tissues based on staining intensity. 
Examples of intensely stained, moderately stained, and weekly stained TMAs are shown 















Figure 13. TMA cores staining intensity comparison. Three tissue cores, categorized as 
strongly stained (A), moderately stained (B), and weekly stained (C), are shown. Tissue core belonging to 
malignant angiosarcoma was stained intensely using anti-Rab24, while liposarcoma was stained weekly. H 
scores are in agreement with the morphology of cells in the tissue cores. One cancer core usually contains 
more than one tissue type; for instance, there may be both connective tissue and epithelial tissue in one 
cancer core. Cancer core H-score is calculated from all scored cells in each cancer core.  Tissue H-score 
belongs only to the cells in one tissue type in a cancer core. Cancer core H-scores were used to compare 
cancer cores with each other in terms of Rab24 expression quantitatively. Tissue H-scores were used to see 
which tissue type (connective, epithelial, or muscle) was stained more intensely. Tissues in one cancer core 
can have similar or different H-scores from their corresponding cancer core depending on the tissue 
heterogeneity in that core. Scale bar: 50 m. 
Malignant angiosarcoma 
Cancer core number 134 
Malignant liposarcoma 
Cancer core number 132 
 
• Cancer core H-score: 41 
• H-score belonging to the connective 
tissue in this cancer core: 45 
 
Malignant leiomyosarcoma 
Cancer core number 103 
• Cancer core H-score: 184 
• H-score belonging to the epithelial tissue 
in this cancer core: 184 
 
• Cancer core H-score: 105 
• H-score belonging to the connective 
tissue in this cancer core: 114 
 





Table 5. Percentage of all scored cells in the cancer cores above categorizing 




H-scores obtained for each cancer core and most of the tissue types corresponding to 






















Percentage of scored cells Malignant angiosarcoma  Malignant leiomyosarcoma Malignant liposarcoma 
1+ 15.74 64.55 39.71 
2+ 82.67 18.94 0.60 
3+ 1.08 0.76 0.05 





Table 6. QuPath analysis. H-scores was calculated using all scored cells in each cancer core. Each 









1  Liver control 1 164 
 
2  Liver control 2 162 
17 
3 
Low-grade appendic mucinous neoplasms  128 
18 Low-grade appendic mucinous neoplasms 152 
19 Low-grade appendic mucinous neoplasms 84 
20 Low-grade appendic mucinous neoplasms 108 
21 Low-grade appendic mucinous neoplasms 140 
22 Low-grade appendic mucinous neoplasms 150 
23 
3 
Benign esophagus epidermoid carcinoma  180 
24 Esophagus epidermoid carcinoma 141 
25 Esophagus epidermoid carcinoma 120 
26 Benign esophagus epidermoid carcinoma 152 
27 Esophagus epidermoid carcinoma 113 
28 Esophagus epidermoid carcinoma 101 
29 Benign esophagus epidermoid carcinoma  51 
30 Esophagus epidermoid carcinoma 183 
31 Esophagus epidermoid carcinoma 175 
32 
3 
Esophagus adenocarcinoma 147 
33 Esophagus adenocarcinoma 163 
34 Esophagus adenocarcinoma 119 
35 Esophagus adenocarcinoma 126 
36 Esophagus adenocarcinoma 89 
37 Esophagus adenocarcinoma 157 
38 
1 
Benign rectal NEC 128 
39 Rectal NEC 206 
40 Rectal NEC 195 
41 
3 
Benign rectal adenocarcinoma 165 
42 Rectal adenocarcinoma 132 
43 Rectal adenocarcinoma 158 
44 Rectal adenocarcinoma 104 
45 Rectal adenocarcinoma 218 
46 Rectal adenocarcinoma 136 
47 Rectal adenocarcinoma 110 
48 1 Small intestine NEC 151 49 Small intestine NEC 146 
50 
3 
Benign small intestine Neuroendocrine Tumor (NET) 
grade 2 
172 
51 Small intestine NET grade 2 121 


















Benign small intestine NET grade 2 130 
54 Small intestine NET grade 2 147 
55 Small intestine NET grade 2 124 
56 Benign small intestine NET grade 2 137 
57 Small intestine NET  grade 2 124 
58 Small intestine NET grade 2 128 
59 
3 
Benign small intestine NET grade 1 175 
60 Small intestine NET grade 1 156 
61 Small intestine NET grade 1 177 
62 Benign small intestine NET grade 1 149 
63 Small intestine NET 1 145 
64 Small intestine NET grade 1 134 
65 Benign small intestine NET grade 1 68 
66 Small intestine NET grade 1 140 
67 Small intestine NET grade 1 140 
68 1 Ileum neuroendocrine carcinoma 149 69 Ileum neuroendocrine carcinoma 138 
70 
2 
Benign stomach and small intestine NEC grade 3  144 
71 Stomach and small intestine NEC 3  182 
72 Stomach and small intestine NEC 3  139 
73 Stomach and small intestine NEC 3  146 
74 Stomach and small intestine NEC 3  151 
75 
3 
Benign stomach diffuse adenocarcinoma 201 
76 Stomach diffuse adenocarcinoma 122 
77 Stomach diffuse adenocarcinoma 116 
78 Stomach diffuse adenocarcinoma 107 
79 Stomach diffuse adenocarcinoma 133 
80 Benign stomach diffuse adenocarcinoma 173 
81 Stomach diffuse adenocarcinoma 135 
82 Stomach diffuse adenocarcinoma 94 
83 
3 
Stomach intestinal adenocarcinoma 109 
84 Stomach intestinal adenocarcinoma 163 
85 Benign stomach intestinal adenocarcinoma 181 
86 Stomach intestinal adenocarcinoma 101 
87 Stomach intestinal adenocarcinoma 108 
88 Benign stomach intestinal adenocarcinoma 134 
89 Stomach intestinal adenocarcinoma 123 




















Rhabdomyosarcoma  54 
92 Rhabdomyosarcoma  96 
93 Benign Rhabdomyosarcoma  60 
94 Rhabdomyosarcoma  80 
95 Rhabdomyosarcoma  78 
96 Rhabdomyosarcoma  148 
97 Rhabdomyosarcoma  107 
98 
4 
Benign leiomyosarcoma  55 
99 Leiomyosarcoma  114 
100 Leiomyosarcoma  107 
101 Benign leiomyosarcoma 127 
102 Leiomyosarcoma  115 
103 Leiomyosarcoma  105 
104 Benign leiomyosarcoma  83 
105 Leiomyosarcoma  74 
106 Leiomyosarcoma  66 
107 Leiomyosarcoma  82 
108 Leiomyosarcoma  59 
109 
3 
Malignant fibrose histocytoma  131 
110 Malignant fibrose histocytoma  122 
111 Malignant fibrose histocytoma  46 
112 Malignant fibrose histocytoma  124 
113 Malignant fibrose histocytoma  127 
114 Benign malignant fibrose histocytoma  33 
115 Malignant fibrose histocytoma  75 
116 Malignant fibrose histocytoma  57 
117 
3 
Benign synovial sarcoma  66 
118 Synovial sarcoma 163 
119 Synovial sarcoma 118 
120 Synovial sarcoma 156 
121 Synovial sarcoma 104 
122 Benifn synovial sarcoma 41 
123 Synovial sarcoma 194 
124 Synovial sarcoma 108 
125 
3 
Benign liposarcoma  96 
126 Liposarcoma  72 
127 Liposarcoma  87 





























129  Liposarcoma  71 
130 Benign liposarcoma  69 
131 Liposarcoma  60 
132 Liposarcoma  41 
133 
3 
Benign Angiosarcoma 49 
134 Angiosarcoma 184 
135 Angiosarcoma 173 
136 Benign Angiosarcoma 186 
137 Angiosarcoma 173 
138 Angiosarcoma 155 
139 Benign Angiosarcoma 34 
140 Angiosarcoma 222 
141 Angiosarcoma 197 
142 
3 
Benign Fibrosarcoma 33 
143 Fibrosarcoma 50 
144 Fibrosarcoma 78 
145 Fibrosarcoma 102 
146 Fibrosarcoma 57 
147 Benign Fibrosarcoma 34 
148 Fibrosarcoma 101 
151 Fibrosarcoma 65 
152 
3 
stomach GIST 206 
153 Benign stomach GIST 165 
154 stomach GIST 181 
155 stomach GIST 203 
156 Benign stomach GIST 92 
157 stomach GIST 119 





Table 7. H-scores in different tissues. The table shows H-scores belonging to epithelial, 











Cancer core number - 
Tissue class H-score 
TMA number - 
class H-score 
TMA number - 
class H-score 
140 - Connective 227 145 - Connective 108 147 - Connective 42 
152 - Connective 209 148 - Connective 105 117 - Connective 35 
155 - Connective 209 127 - Connective 92 103 - Connective 114 
123 - Connective 202 36 - Connective 89 114 - Connective 32 
141 - Connective 202 156 - Connective 87 
154 - Connective 186 144 - Connective 86 
33 - Connective 175 136 - Connective 85 
153 - Connective 171 126 - Connective 81 
118 - Connective 166 115 - Connective 81 
109 - Connective 138 128 - Connective 76 
35 - Connective 137 130 - Connective 76 
42 - Connective 137 65 - Connective 75 
32 - Connective 134 129 - Connective 74 
113 - Connective 132 111 - Connective 70 
112 - Connective 132 17 - Connective 66 
34 - Connective 131 116 - Connective 66 
158 - Connective 129 151 - Connective 65 
110 - Connective 128 146 - Connective 65 
119 - Connective 125 18 - Connective 65 
157 - Connective 123 125 - Connective 63 
45 - Connective 122 131 - Connective 59 
120 - Connective 122 143 - Connective 55 
21 - Connective 120 133 - Connective 54 
124 - Connective 116 142 - Connective 46 
23 - Connective 111 132 - Connective 45 


































Cancer core number – Tissue 
class H-score 
TMA number - 
class H-score 
96 - Connective and muscle 151 18 - Epithelial 259 
81 - Connective and muscle 141 22 - Epithelial 253 
89 - Connective and muscle 133 17 - Epithelial 253 
76 - Connective and muscle 127 136 - Epithelial 253 
97 - Connective and muscle 123 80 - Epithelial 247 
102 - Connective and muscle 118 45 - Epithelial 241 
79 - Connective and muscle 117 23 - Epithelial 228 
100 - Connective and muscle 114 39 - Epithelial 221 
83 - Connective and muscle 111 40 - Epithelial 215 
90 - Connective and muscle 110 88 - Epithelial 209 
22 - Connective and muscle 106 75 - Epithelial 206 
20 - Connective and muscle 105 50 - Epithelial 183 
78 - Connective and muscle 103 134 - Epithelial 184 
80 - Connective and muscle 101 71 - Epithelial 181 
92 - Connective and muscle 99 79 - Epithelial 178 
82 - Connective and muscle 97 137 - Epithelial 178 
19 - Connective and muscle 95 135 - Epithelial 173 
77 - Connective and muscle 93 21 - Epithelial 171 
101 - Connective and muscle 93 37 - Epithelial 156 
94 - Connective and muscle 90 138 - Epithelial 150 
107 - Connective and muscle 86 72 - Epithelial 139 
95 - Connective and muscle 85 
104 - Connective and muscle 76 
105 - Connective and muscle 76 
108 - Connective and muscle 72 
106 - Connective and muscle 71 
88 - Connective and muscle 71 






















Lastly, five cancer types were selected as candidates for further investigation in the future. 
Angiosarcoma, stomach GIST and rectal NEC were selected due to their high H-score 







Cancer core number – 
Tissue class H-score 
78 - Muscle 139 
21 - Muscle 137 
99 - Muscle 120 
51 - Muscle 109 
86 - Muscle 98 
87 - Muscle 88 

















Figure 14. IHC staining of selected cancer cores with high H-scores. Most cancer cores 
in three cancer types, angiosarcoma (A), stomach GIST (B), and rectal NEC (C), were ranked higher than 
180 by the H-score index. Further information can be found in the figure legend 13. Scale bar: 50 m. 
Table 8. Percentage of all scored cells in cancer cores above categorizing in different 
intensity groups. 
Percentage of scored cells Malignant angiosarcoma  Malignant stomach GIST Malignant rectal NEC 
1+ 15.74 6.32 13.89 
2+ 82.67 83.72 53.14 
3+ 1.08 9.81 24.91 
negative 0.46 0.15 8.07 
Malignant angiosarcoma 
Cancer core number  134 
Malignant stomach GIST 
Cancer core number 155 
• Cancer core H-score: 184 
• H-score belonging to the epithelial tissue 
in this cancer core: 184 
 
• Cancer core H-score: 203 
• H-score belonging to the connective 
tissue in this cancer core: 209 
 
Malignant rectal NEC 
Cancer core number 40 
• Cancer core H-score: 195 
• H-score belonging to the epithelial tissue 
in this cancer core: 215 
 

















Figure 15. Selected cancer cores with low H-scores. Most cancer cores in two cancer types, 
liposarcoma (A) and fibrosarcoma (B), were ranked lower than 90 by the H-score index.  Only little 
fluctuation was observed among different patient’s H-score in each of these two cancer types. Further 
information can be found in the figure legend 13. Scale bar: 50 m.  






Percentage of scored cells Malignant liposarcoma  Malignant fibrosarcoma 
1+ 39.71 46.23 
2+ 0.60 1.59 
3+ 0.05 0.04 
negative 59.64 52.14 
Liposarcoma 
Cancer core number 132 
Fibrosarcoma  
Cancer core number 143 
 
A) B) 
• Cancer core H-score: 41 
• H-score belonging to the connective 
tissue in this cancer core: 45 
 
• Cancer core H-score: 50 
• H-score belonging to the connective 








In this project, we screened Rab24 expression in TMA samples containing cores from 21 
different human cancers. Collaboration with Professor Ilmo Leivo, an expert in 
pathology, and implementation of state-of-the-art quantification techniques 
simultaneously made this study a building block for future discoveries. An instant nuclei 
segmentation method is urgently needed for accurate quantification of histological 
staining. Therefore, I developed image analysis pipelines that provided a reliable and 
precise quantification.   
Initially, I detected and scored the cells using " positive cell detection” command in 
QuPath. This command was not efficient for analysis even though I optimized the 
parameters, as it was developed mainly to detect the positive staining in the nuclei, while 
Rab24 is localized mainly in the cytoplasm. The analysis using "positive cell detection" 
command resulted in many false detections and over segmentations. Hence, I combined 
the QuPath with a deep learning network known as StarDist that is well-adapted to the 
typical shape of the nuclei to detect and score the cells. This method showed very 
promising results and minimized the errors to a great degree. 
The following steps were taken in the project: 
• Checking antibody validity 
• Performing IHC on the tissue sections 
• Discussion with the pathologist 
• Image analysis and quantification 
 
Using the rabbit anti-Rab24, we detected unknown positive bands in Western blots of the 
Neuro-2a cell lines, including Rab24 -/- cells. This suggests that the antibody may give 
unspecific signals in IHC staining as well. Therefore, the results reported for the different 







It is important to point out that IHC using DAB as chromogen has some limitations as a 
quantitative method. This is because antigen/antibody amplification steps used during the 
IHC staining function in a non-linear fashion, and because DAB is not a true absorber of 
light. To ensure that results are sufficiently specific and sensitive, I implemented careful 
calibration using on-slide control tissues that showed low protein expression levels 
(Adding quality to your qualitative IHC | Medical Laboratory Observer).The analysis 
revealed angiosarcoma, stomach GIST, rectal NEC, liposarcoma, and fibrosarcoma as 
interesting cancer types for future studies.  
As identification of cancer cells and benign cells in histology samples is challenging, 
further discussions with pathology experts are needed regarding the selected cancer types 
in order to draw firm conclusions on Rab24 expression in cancer and normal cells.  
The findings also need to be investigated in a higher number of samples from a higher 
number of patients to gather data about the possible prognostic value of Rab24 expression 
in these cancers. Analyzing additional samples will also reveal whether there is a 
correlation between patients’ survival and RAB24 expression. 
The path toward success: 
Cancer cores often contained multiple tissue types; therefore, I used manual classification 
and cell training classifier in QuPath to determine the tissue types and their H-scores 
individually.  Classification revealed which tissue types were stained more positive 
compared to others.  Despite the advanced "cell training classifier" command in open-
source products such as QuPath and ImageJ-Fiji software, distinguishing different cell 
types, such as epithelial, connective, and muscle cells, is quite a challenge. "Training the 
cell classifier" command showed a high accuracy to classify cells that differ in intensity, 
but it cannot recognize the differences in the morphology yet. Thus, manual classification 
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